Lassa fever: another threat from West Africa

Lassa fever, a zoonotic viral infection, is endemic in West Africa. The disease causes annual wide spread morbidity and mortality in Africa, and can be imported by travelers. Possible importation of Lassa fever and the potential for the use of Lassa virus as an agent of bioterrorism mandate clinicia...

Descripción completa

Detalles Bibliográficos
Autor principal: Brosh-Nissimov, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330145/
https://www.ncbi.nlm.nih.gov/pubmed/28265442
http://dx.doi.org/10.1186/s40696-016-0018-3
_version_ 1782511204043849728
author Brosh-Nissimov, Tal
author_facet Brosh-Nissimov, Tal
author_sort Brosh-Nissimov, Tal
collection PubMed
description Lassa fever, a zoonotic viral infection, is endemic in West Africa. The disease causes annual wide spread morbidity and mortality in Africa, and can be imported by travelers. Possible importation of Lassa fever and the potential for the use of Lassa virus as an agent of bioterrorism mandate clinicians in Israel and other countries to be vigilant and familiar with the basic characteristics of this disease. The article reviews the basis of this infection and the clinical management of patients with Lassa fever. Special emphasis is given to antiviral treatment and infection control.
format Online
Article
Text
id pubmed-5330145
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53301452017-03-06 Lassa fever: another threat from West Africa Brosh-Nissimov, Tal Disaster Mil Med Review Lassa fever, a zoonotic viral infection, is endemic in West Africa. The disease causes annual wide spread morbidity and mortality in Africa, and can be imported by travelers. Possible importation of Lassa fever and the potential for the use of Lassa virus as an agent of bioterrorism mandate clinicians in Israel and other countries to be vigilant and familiar with the basic characteristics of this disease. The article reviews the basis of this infection and the clinical management of patients with Lassa fever. Special emphasis is given to antiviral treatment and infection control. BioMed Central 2016-04-30 /pmc/articles/PMC5330145/ /pubmed/28265442 http://dx.doi.org/10.1186/s40696-016-0018-3 Text en © Brosh-Nissimov. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Brosh-Nissimov, Tal
Lassa fever: another threat from West Africa
title Lassa fever: another threat from West Africa
title_full Lassa fever: another threat from West Africa
title_fullStr Lassa fever: another threat from West Africa
title_full_unstemmed Lassa fever: another threat from West Africa
title_short Lassa fever: another threat from West Africa
title_sort lassa fever: another threat from west africa
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330145/
https://www.ncbi.nlm.nih.gov/pubmed/28265442
http://dx.doi.org/10.1186/s40696-016-0018-3
work_keys_str_mv AT broshnissimovtal lassafeveranotherthreatfromwestafrica

Ejemplares similares